Subscribe

Al Hammadi Holding Company (4007.SR)

SAR26.96 -0.06 (-0.22%)
SA SAU Healthcare Medical - Care Facilities
Address PO Box 55004 11534
Riyadh, Riyadh Province, SA
CEO Mohammed Bin Saleh Bin Mohammed Al Hammadi
Website alhammadi.com
IPO 2014-07-15
ISIN SA13J051UJH4

Explore sections of this company profile

Description

Established in Riyadh, Saudi Arabia, in 1985, Al Hammadi Holding Company specializes in the healthcare industry. Its core operations include the development, upkeep, and management of hospitals and medical centers across the Kingdom, primarily through its Medical Services and Pharmaceuticals Products divisions. Beyond direct healthcare provision, the company diversifies its business into the wholesale and retail distribution of medical equipment, pharmaceuticals, cosmetic products, and food and beverages. Al Hammadi also holds interests in real estate, acquiring and leasing land for construction, invests in various industrial ventures, and is involved in establishing and managing commercial centers. The company currently operates three healthcare facilities under the Al Hammadi Hospital brand, located in the Olaya, Suwaidi, and Al Nuzha districts of Riyadh.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SAR26.96 -0.06 (-0.22%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
242.9K
Beta
0.01
Float Shares
125.49M
Free Float %
78.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.08% +8.12% -10.64% -5.79% -29.99% -50.36% +2.17% -14.33% +82.55%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
26.96
DCF (Unlevered) 105.26 +290.4%
DCF (Levered) 104.72 +288.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 71% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 3 0
Hold 2 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.88
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +7.0% Q1'26: +5.7% (vs Q1'25)
  • ✗
    EPS growth Medical - Care Facilities: +19.2%
    -28.8% Q1'26: -23.9% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    -0.5% Q1'26: -24.5% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +18.6% ★ Q1'26: +14.7% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +9.9% ★ Q1'26: +7.7% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.1% Q1'26: +0.4% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.90× ★ Q1'26: 1.03× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.01) × ERP
WACC = 94% × Ke + 6% × Kd (6.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 105.26 Current price: 26.96
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
4 Rev. Ana.
4 EPS Ana. 		Dec 2027
4 Rev. Ana.
4 EPS Ana. 		Dec 2028
2 Rev. Ana.
3 EPS Ana. 		Dec 2029
3 Rev. Ana.
2 EPS Ana. 		Dec 2030
3 Rev. Ana.
2 EPS Ana.
Revenue
561.33M
est: 581.46M (-3.5%)
481.96M
est: 607.41M (-20.7%)
708.62M
est: 730.16M (-2.9%)
893.60M
est: 930.98M (-4.0%)
974.06M
est: 937.50M (+3.9%)
991.81M
est: 971.50M (+2.1%)
951.89M
est: 900.55M (+5.7%)
1.12B
est: 1.08B (+4.0%)
1.18B
est: 1.14B (+3.0%)
1.15B
est: 1.15B (+0.3%)
1.23B
est: 1.23B (+0.7%)
1.36B
1.36B – 1.37B
+11.3% YoY
1.54B
1.53B – 1.55B
+12.8% YoY
1.73B
1.72B – 1.74B
+12.6% YoY
1.93B
1.92B – 1.94B
+11.2% YoY
2.05B
2.04B – 2.06B
+6.5% YoY
EBITDA
156.52M
est: 184.41M (-15.1%)
153.41M
est: 192.63M (-20.4%)
187.50M
est: 231.57M (-19.0%)
224.22M
est: 295.25M (-24.1%)
246.42M
est: 297.32M (-17.1%)
198.83M
est: 308.10M (-35.5%)
228.80M
est: 285.60M (-19.9%)
396.27M
est: 342.30M (+15.8%)
446.86M
est: 352.87M (+26.6%)
475.49M
est: 355.45M (+33.8%)
318.45M
est: 378.82M (-15.9%)
421.72M
419.73M – 423.72M
+11.3% YoY
475.51M
471.28M – 479.75M
+12.8% YoY
535.23M
532.70M – 537.76M
+12.6% YoY
595.11M
592.30M – 597.92M
+11.2% YoY
633.89M
630.89M – 636.89M
+6.5% YoY
EBIT
156.52M
est: 131.45M (+19.1%)
103.00M
est: 137.31M (-25.0%)
140.86M
est: 165.06M (-14.7%)
135.79M
est: 210.46M (-35.5%)
144.01M
est: 211.94M (-32.0%)
107.38M
est: 219.62M (-51.1%)
129.24M
est: 203.58M (-36.5%)
295.86M
est: 244.00M (+21.3%)
346.76M
est: 305.03M (+13.7%)
378.50M
est: 307.27M (+23.2%)
229.27M
est: 327.47M (-30.0%)
364.56M
362.83M – 366.28M
+11.3% YoY
411.06M
407.40M – 414.72M
+12.8% YoY
462.68M
460.49M – 464.87M
+12.6% YoY
514.44M
512.01M – 516.87M
+11.2% YoY
547.96M
545.37M – 550.55M
+6.5% YoY
Net Income
141.33M
est: 143.31M (-1.4%)
74.68M
est: 90.59M (-17.6%)
107.96M
est: 115.49M (-6.5%)
89.81M
est: 97.44M (-7.8%)
93.00M
est: 92.06M (+1.0%)
130.83M
est: 134.50M (-2.7%)
90.09M
est: 105.68M (-14.8%)
257.34M
est: 241.75M (+6.4%)
303.33M
est: 321.98M (-5.8%)
338.80M
est: 337.02M (+0.5%)
241.86M
est: 252.90M (-4.4%)
260.84M
259.24M – 262.44M
+3.1% YoY
288.38M
278.93M – 297.83M
+10.6% YoY
325.66M
323.65M – 327.66M
+12.9% YoY
372.40M
370.11M – 374.69M
+14.4% YoY
405.24M
402.74M – 407.73M
+8.8% YoY
SGA
86.86M
est: 11.97M (+625.4%)
131.16M
est: 12.51M (+948.6%)
13.64M
est: 15.04M (-9.3%)
14.17M
est: 19.17M (-26.1%)
24.17M
est: 19.31M (+25.2%)
25.30M
est: 20.01M (+26.5%)
16.76M
est: 18.55M (-9.6%)
21.96M
est: 22.23M (-1.2%)
26.14M
est: 23.59M (+10.8%)
20.86M
est: 23.76M (-12.2%)
31.89M
est: 25.33M (+25.9%)
28.19M
28.06M – 28.33M
+11.3% YoY
31.79M
31.51M – 32.07M
+12.8% YoY
35.78M
35.61M – 35.95M
+12.6% YoY
39.79M
39.60M – 39.97M
+11.2% YoY
42.38M
42.18M – 42.58M
+6.5% YoY
EPS
0.89
est: 0.90 (-0.6%)
0.47
est: 0.57 (-17.0%)
0.68
est: 0.72 (-5.8%)
0.56
est: 0.61 (-8.0%)
0.58
est: 0.58 (+0.8%)
0.82
est: 0.84 (-2.5%)
0.56
est: 0.66 (-15.2%)
1.61
est: 1.52 (+6.2%)
1.90
est: 2.01 (-5.6%)
2.12
est: 2.10 (+0.8%)
1.51
est: 1.58 (-4.3%)
1.63
1.62 – 1.64
+3.2% YoY
1.80
1.74 – 1.86
+10.6% YoY
2.03
2.02 – 2.05
+12.9% YoY
2.33
2.31 – 2.34
+14.4% YoY
2.53
2.51 – 2.55
+8.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-21 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-20 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-19 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-18 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-17 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-14 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-13 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-12 C 2/5 4/5 1/5 1/5 1/5 2/5 1/5
2026-05-11 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-10 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-07 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-06 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-05 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-04 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-05-03 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-30 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-29 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-28 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-27 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-26 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-23 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-22 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-21 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-20 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-19 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-16 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
242.26M
OE per share TTM
1.51
Owner's Yield
5.72%
Maintenance CapEx ratio
8.29%
Maint CapEx / Avg PPE
154.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 47 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares MSCI Saudi Arabia ETF KSA 0.20% 1.33M 0.75%
2 iShares MSCI Emerging Markets Small-Cap ETF EEMS 0.03% 125.9K 0.72%
3 iShares MSCI EM Small Cap UCITS ETF IEMS.L 0.03% 107.0K 0.74%
4 State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L 0.03% 153.8K 0.55%
5 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.01% 1.99M 0.06%
6 Avantis Emerging Markets Small Cap Equity ETF AVEE 0.01% 12.6K 0.42%
7 Dimensional Emerging Markets Sustainability Core 1 ETF DFSE 0.01% 49.0K 0.44%
8 Dimensional - Emerging Markets Core Equity 2 ETF DFEM 0.01% 707.6K 0.39%
9 State Street SPDR Morningstar Multi-Asset Global Infrastructure UCITS ETF (Dist) MAGI.L 0.01% 72.1K 0.40%
10 Dimensional - Emerging Markets Value ETF DFEV 0.01% 101.9K 0.46%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
70.7K
Shares Outstanding
160.00M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Mohammed Bin Saleh Bin Mohammed Al Hammadi MD, CEO & Vice-Chairman 200.0K male
Majid Bin Saleh Al-Salem Al-Nahdi Human Resources Director — male
Mohammed Saeed Suleiman Al Saafeen Finance Manager & Chief Financial Officer — male
Mohammed Said Suleiman Al Saafin Finance Manager & Chief Financial Officer — male
Reema Saleh Al Hammadi Chief Medical Officer & Director — —
Safug Al Koraisi Head of Intensive Care Units — —
Wahid Raafat Mohamed Chief Internal Audit Executive — male
Daifallah Al Nakhli Head of Infection Control — —
Walid Fathi Abdulkhaleq Al Kawamleh Marketing Director — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities